Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
- Conditions
- Hematopoietic Stem Cell TransplantPoor Marrow Graft Function
- Interventions
- Device: CliniMACS Cell Selection System
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT02350777
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
- Conditions
- Neuroendocrine Tumors
- Interventions
- Radiation: 18F-MFBG (meta-fluoro benzylguanidine)Device: Positron emission tomography (PET) imagingOther: Blood draws
- First Posted Date
- 2015-01-28
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 48
- Registration Number
- NCT02348749
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas
- Conditions
- T-cell LymphomasRelapsed or Refractory
- Interventions
- First Posted Date
- 2015-01-19
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT02341014
- Locations
- 🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies
- Conditions
- Pancreatic CancerUnresectable Biliary-pancreatic Malignancies
- Interventions
- Device: ERCP with SEMS alone (standard of care)Device: ERCP with SEMS plus radiofrequency ablation
- First Posted Date
- 2015-01-19
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT02340728
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases
- Conditions
- Spinal Metastases
- Interventions
- Radiation: single-fraction SRSRadiation: high-dose hypofractionated SRSBehavioral: Quality of Life Measures
- First Posted Date
- 2014-12-19
- Last Posted Date
- 2019-02-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT02320825
- Locations
- 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸John Hopkins Medical Center, Baltimore, Maryland, United States
Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)
- Conditions
- Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL)Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
- Interventions
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 109
- Registration Number
- NCT02315326
- Locations
- 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
- Conditions
- Prostate Cancer
- Interventions
- Device: multi-parametric MRI(MP-MRI)Device: dynamic contrast-enhanced MRI (DCE)Procedure: biopsy
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 120
- Registration Number
- NCT02312401
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening
- Conditions
- Breast Cancer Screening
- Interventions
- Device: contrast enhanced digital mammography (CEDM)Device: whole breast screening ultrasound (WBUS)
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 487
- Registration Number
- NCT02310698
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma
- Conditions
- T-cell LymphomaRelapsed and Refractory T-cell Lymphoma
- Interventions
- First Posted Date
- 2014-12-05
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 14
- Registration Number
- NCT02309580
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Ohio State University, Columbus, Ohio, United States
Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
- Conditions
- Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related MalignanciesHuman Papillomavirus (HPV)-Related Malignancies
- Interventions
- First Posted Date
- 2014-12-04
- Last Posted Date
- 2023-01-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT02308241
- Locations
- 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States